Today, the U.S. Preventive Services Task Force released a draft recommendation that colorectal cancer screening should begin at age 45. The recommendation to screen applies to all adults 45-75 years old without symptoms, a personal history of colorectal polyps or a personal or family history of genetic disorders that increase the risk of colorectal cancer.
Massey scientist awarded $1.7M to identify drugs that can overcome chemotherapy resistance and effectively treat advanced breast cancer
Triple-negative breast cancer (TNBC) is an aggressive form of disease that makes up about 10-15% of all breast cancers, according to the American Cancer Society. Because these tumors grow faster, and there are limited treatment options, patient outcomes are worse compared to other types of breast cancer. Chuck Harrell, Ph.D., member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center, was recently awarded a $1.7 million R01 grant from the National Cancer Institute to identify targeted drugs that can overcome chemotherapy resistance and effectively treat TNBC.
Mary Helen Hackney, M.D., M.S., FACP, has been named medical director of community oncology at VCU Massey Cancer Center and VCU School of Medicine. She is an associate professor and the director of quality improvement in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine at the VCU School of Medicine.
Masey Ross, M.D., M.S., has been appointed medical director of clinical research affiliations at VCU Massey Cancer Center and VCU School of Medicine. She is also the medical director of Massey’s Integrative Health Program and an assistant professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine at the VCU School of Medicine.
Cervical cancer is the most common cancer in women worldwide. Finding effective therapies requires clinical trials, which can offer new options when other treatments have failed.
Leslie Randall, M.D., director of gynecologic oncology and a researcher at VCU Massey Cancer Center, discusses cervical cancer treatment, advances and current clinical trials underway at VCU Massey Cancer Center.